Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Xue Song, Liang ^a   Cheng Zhong, Li ^a   Ying, Zhou ^b   Mo Bin, Wan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HBV; Immune; Th17; Treg

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; VIRUS DNA;

ACUTE HEPATITIS; ACUTE ON CHRONIC HEPATITIS B VIRUS RELATED LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LIVER FAILURE; LYMPHOCYTE DIFFERENTIATION; MALE; NONHUMAN; REGULATORY T LYMPHOCYTE; TH17 CELL; VIRUS CARRIER; VIRUS LOAD;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD4; CASE-CONTROL STUDIES; CELL COUNT; CELL DIFFERENTIATION; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-17; LIVER FAILURE; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VIRAL LOAD;

EID: 84862239357     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-43     Document Type: Article

References (32)

1. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129. 10.1056/NEJMra031087, 15014185.
2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403. 10.1016/S1473-3099(02)00315-8, 12127351.
3. Bertoletti A, Maini M, Williams R. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res 2003, 60:61-66. 10.1016/j.antiviral.2003.08.012, 14638412.
4. Lohse AW, Weiler-Normann C, Tiegs G. Immune-mediated liver injury. J Hepatol 2010, 52:136-144. 10.1016/j.jhep.2009.10.016, 19913936.
5. Jung MC, Gerd RP. Immunology of hepatitis B infection. Lancet Infect Dis 2001, 2:43-50.
6. Wang FS. Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: progress and challenges. Hepatol Res 2007, 37:S339-S346. 10.1111/j.1872-034X.2007.00222.x, 17931184.
7. Beacher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
8. Sakaguchi S. Naturally arising CD4 + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immuno 2004, 22:531-562.
9. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. FoxP3 + CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27. 10.1111/j.0105-2896.2006.00427.x, 16903903.
10. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005, 41(4):771-778. 10.1002/hep.20649, 15791617.
11. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008, 123(1):57-65. 10.1111/j.1365-2567.2007.02691.x, 2433275, 17764450.
12. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177(1):739-747.
13. O'Quinn DB, Palmer MT, Lee YM, Weaver CT. Emergence of the Th17 pathway and its role in host defense. Adv Immunol 2008, 99:115-163.
14. Sieve AN, Meeks KD, Bodhankar S, Lee S, Kolls JK, Simecka JW, Berg RE. A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol 2009, 39:426-438. 10.1002/eji.200838726, 2735239, 19180464.
15. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS. Interleukin-17-producing CD4 + T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51:81-91. 10.1002/hep.23273, 19842207.
16. Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010, 25(4):750-757. 10.1111/j.1440-1746.2009.06154.x, 20492330.
17. Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, Yu X, Zhang W, Wu J, Zheng S. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol 2010, 30(4):546-555. 10.1007/s10875-010-9416-3, 20393789.
18. Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010, 30(1):60-67. 10.1007/s10875-009-9328-2, 19756987.
19. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007, 7:804-813. 10.1016/S1473-3099(07)70289-X, 18045563.
20. Zhang J-Y, Song C-H, Shi F, Zhang Z, Fu J-L, Wand F-S. Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment. PLoS One 2010, 5(11):e13869. 10.1371/journal.pone.0013869, 2975625, 21079784.
21. Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol 2011, 24(4):303-310. 10.1089/vim.2010.0135, 21721931.
22. Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 2009, 21:274-280. 10.1016/j.coi.2009.05.021, 19524429.
23. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(7090):235-238. 10.1038/nature04753, 16648838.
24. Bouchliou I, Miltiades P, Nakou E, Spanoudakis E, Goutzouvelidis A, Vakalopoulou S, Garypidou V, Kotoula V, Bourikas G, Tsatalas C, Kotsianidis I. Th17 and Foxp3 + T regulatory cell dynamics and distribution in Myelodysplastic syndromes. Clinical Immunol 2011, 139:350-359.
25. Wang Q, Zheng Y, Huang Z, Tian Y, Zhou J, Mao Q, Wu Y, Ni B. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol 2011, 12:25. 10.1186/1471-2172-12-25, 3094328, 21489307.
26. Oukka M. Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis 2007, 66:iii87-iii90. 10.1136/ard.2007.078527, 2095282, 17934104.
27. Weaver CT, Hatton RD. Interplay between the Th17 and Treg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 2009, 9:883-889. 10.1038/nri2660, 19935807.
28. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240. 10.1038/nature06878, 2597437, 18368049.
29. Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G, Gao Z, Liu H, Chen X, Zhou B. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J 2011, 8:270-275. 10.1186/1743-422X-8-270, 3118363, 21639870.
30. Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y. The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta 2010, 411:1963-1968. 10.1016/j.cca.2010.08.013, 20713031.
31. Li J, Wang L, Wang S, Zhu H, Ye P, Xie A, Shen B, Liu C, Guo C, Fu Q, Zhang K, Xia J. The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol 2010, 71:298-303. 10.1111/j.1365-3083.2010.02374.x, 20384874.
32. Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, Zhang S, Lin S, Zhao Y. The balance between intrahepatic IL-17 + T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011, 12:47-55. 10.1186/1471-2172-12-47, 3176252, 21851644.